Clinical Trial Update: Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating rituximab for opsoclonus–myoclonus associated with neuroblastoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Opsoclonus-myoclonus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Jean M. Tersak, M.D. | Conditions: Neuroblastoma, Opsoclonus-myoclonus | Phase 2 | Status: TERMINATED | Results posted: 2021-01-22